 |
인쇄하기
취소
|
Lilly willing to cooperate with Korean scientists over MDR-TB programs
Eli Lilly, a U.S.-based pharmaceutical company, plans to expand its research programs to fight multidrug-resistant tuberculosis (MDR-TB) with Korean scientists.
“We have talked with Korea’s research institutes including the Korea Advanced Institute of Science and Technology for the MDR-TB programs and hope to collaborate with Korean scientists soon,” Lilly’s Vice President Gail Cassell, who ...
“We have talked with Korea’s research institutes including the Korea Advanced Institute of Science and Technology for the MDR-TB programs and hope to collaborate with Korean scientists soon,” Lilly’s Vice President Gail Cassell, who ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.